Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model.

Transgenic mouse lineages were established that carry the normal (M) or mutant (Z) alleles of the human alpha 1-antitrypsin (alpha 1-Pi) gene. All of the alpha 1-Pi transgenic mice expressed the human protein in the liver, cartilage, gut, kidneys, lymphoid macrophages, and thymus. The human M-allele protein was secreted normally into the serum. However, the human Z-allele protein accumulated in several cell types, but particularly in hepatocytes, and was found in serum in tenfold lower concentrations than the M-allele protein. Mice in one lineage carrying the mutant Z allele expressed high levels of human alpha 1-Pi RNA and displayed significant runting (50% of normal weight) in the neonatal period. This lineage was found to have alpha 1-Pi-induced liver pathology in the neonatal period, concomitant with the accumulation of human Z protein in diastase-resistant cytoplasmic globules that could be revealed in the Periodic acid-Schiff reaction (PAS). The phenotype of mice in the strain expressing high levels of the Z allele is remarkably similar to human neonatal hepatitis, and this strain may prove to be a useful animal model for studying this disease.

[1]  J. Carlson,et al.  Multiple tissues express alpha 1-antitrypsin in transgenic mice and man. , 1988, The Journal of clinical investigation.

[2]  E. Wagner,et al.  The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. , 1987, Nucleic acids research.

[3]  R. Lovell-Badge,et al.  Species- and tissue-specific expression of human alpha 1-antitrypsin in transgenic mice. , 1987, Genes & development.

[4]  F. DeMayo,et al.  Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. , 1987, Nucleic acids research.

[5]  R. Carrell,et al.  Human α1 ‐antitrypsin expression in Xenopus oocytes , 1985 .

[6]  H. Colten,et al.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Barbatis,et al.  Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. , 1981, The New England journal of medicine.

[8]  T Sveger,et al.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.

[9]  J. Jeppsson Amino acid substitution Glu→Lys in α1‐antitrypsin PiZ , 1976 .

[10]  A. Yoshida,et al.  Molecular abnormality of human alpha1-antitrypsin variant (Pi-ZZ) associated with plasma activity deficiency. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[11]  F. Callea,et al.  Detection of Pi Z phenotype individuals by alpha-1-antitrypsin (AAT) immunohistochemistry in paraffin-embedded liver tissue specimens. , 1986, Journal of hepatology.